Development of biomarker use in oncology clinical trials 2019
Key Findings and Implications
This document, published in cooperation by PMC (Personalized Medicine Coalition) and L.E.K. Consulting in November 2019, presents the latest information on the use of biomarkers in oncologic clinical trials. Biomarkers are the key for implementing personalized treatments to patients, and especially cancer patients.